Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06040502 · ClinicalTrials.gov registry record · NA
Reducing Inappropriate Medication Use for BPSD
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT06040502 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 103 participants.
The verdict
NCT06040502, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
Investigators previously developed a low-cost, practical, patient- and care partner-centric, evidence-informed systematic approach (the "DICE Approach" or DICE), to assess and manage behavioral and psychological symptoms of dementia (BPSD). The goals of this proposal are to refine and test the application of DICE in primary care clinics by: (a) using existing clinic staff to deliver DICE; and (b) using the electronic medical record to identify and recruit PLWD (persons living with dementia) and their care partners (n=100) based on criteria that are clinically meaningful and inclusive of the maximum number of participants in the most equitable way. Clinic-based social workers in four primary care practices at University of California Davis (UCD) will coordinate behavioral management using DICE with care partners, PLWD and other clinic providers. Outcomes will include: 1) feasibility/ability to carry out the approach; 2) acceptability to PLWD and their care partners; and 3) the ability to measure psychiatric medication use and health care use in the electronic medical record. Findings from this study will guide the design of a much larger future study using the DICE Approach to improve outcomes for PLWD and their care partners.
Interventions
- BEHAVIORAL The DICE Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2023-07-12 |
| Est. Completion | 2024-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06040502
The ClinicalTrials.gov registry entry for NCT06040502 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The DICE Approach is the first listed.
NCT06040502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06040502 about?
NCT06040502 is a clinical study titled "Reducing Inappropriate Medication Use for BPSD". Investigators previously developed a low-cost, practical, patient- and care partner-centric, evidence-informed systematic approach (the "DICE Approach" or DICE), to assess and manage behavioral and psychological symptoms of dementia (BPSD). The goals of this proposal are to refine and test the appl...
What is the current status of trial NCT06040502?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2023-07-12. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT06040502?
The interventions under investigation include: The DICE Approach (BEHAVIORAL).
Who is sponsoring clinical trial NCT06040502?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.